| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_f1aa1df0578ff00eb361b445097da206
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_a19f736e9a12c3e9e1330a750d7f5038 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K35-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-685
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-70
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-702
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-7028 |
| filingDate |
2008-04-28^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6751850dafec9dc85fbaca198f17816e |
| publicationDate |
2008-11-06^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-2008133534-A2 |
| titleOfInvention |
Carbohydrate-lipid constructs and their use in preventing or treating viral infection |
| abstract |
The invention relates to selected carbohydrate-lipid constructs and their use as mimics of ligands for receptors expressed by a virus. In particular, the invention relates to the use of selected carbohydrate-lipid constructs in methods of inhibiting virus infection and/or promoting clearance of virus from infected subjects. Carbohydrate-lipid constructs selected for use in these methods where the virus is Human Immunodeficiency Virus (HIV) are provided. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11073451-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/GB-2564917-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2016072863-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2016185331-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-108137627-A |
| priorityDate |
2007-04-27^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |